Evidence map›Paper›PMID 40027353›Full record

ArticleFrontiers in allergy2025

Corrigendum: A novel assay of excess plasma kallikrein-kinin system activation in hereditary angioedema.

Dan Sexton, Ryan Faucette, Melody Rivera-Hernandez, Jon A Kenniston, Nikolaos Papaioannou, Janja Cosic, Kris Kopacz, Gary Salmon, Chantal Beauchemin, Salomé Juethner and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in allergy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Dan SextonTakeda Development Center Americas Inc., Cambridge, MA, United States.
Ryan FaucetteTakeda Development Center Americas Inc., Cambridge, MA, United States.
Melody Rivera-HernandezTakeda Development Center Americas Inc., Cambridge, MA, United States.
Jon A KennistonTakeda Development Center Americas Inc., Cambridge, MA, United States.
Nikolaos PapaioannouTakeda Development Center Americas Inc., Cambridge, MA, United States.
Janja CosicTakeda Development Center Americas Inc., Cambridge, MA, United States.
Kris KopaczTakeda Development Center Americas Inc., Cambridge, MA, United States.
Gary SalmonCharles River Laboratories, Harlow, United Kingdom.
Chantal BeaucheminTakeda Development Center Americas Inc., Cambridge, MA, United States.
Salomé JuethnerTakeda Pharmaceuticals USA, Inc., Lexington, MA, United States.
Dave YeungTakeda Development Center Americas Inc., Cambridge, MA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/falgy.2024.1436855.].

Indexed as

biomarkersbradykininhereditary angioedemaphage displayplasma kallikrein

Identifiers

PMID40027353
PMCPMC11867937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.